|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/195 | |
| A61K 47/00 | |||
| A61L 9/04 | |||
| A61K 47/02 | |||
| A61K 9/00 | |||
| A61K 31/197 | |||
| A61K 31/192 |
| (11) | Patento numeris | 2167071 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08770940.8 |
| Europos patento paraiškos padavimo data | 2008-06-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-03-31 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-03-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/066831 |
| Data | 2008-06-13 |
| (87) | Numeris | WO 2008/157288 |
| Data | 2008-12-24 |
| (30) | Numeris | Data | Šalis |
| 943729 P | 2007-06-13 | US |
| (72) |
MEYTHALER, Jay, M., US
TUEL, Stephen, M., US
|
| (73) |
Wayne State University Board Of Governors,
656 W. Kirby, Detroit, MI 48202,
US
Phase V. Pharmaceuticals, Inc., 2139 Darcy Green Place, Silver Spring, MD 20910, US |
| (54) | A BACLOFEN SOLUTION FOR LOW-VOLUME THERAPEUTIC DELIVERY |
| A BACLOFEN SOLUTION FOR LOW-VOLUME THERAPEUTIC DELIVERY |